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Vascular Surgery, Royal Free Hospital Hampstead NHS Trust, London, UKWhen autologous vein is unavailable, prosthetic graft materials, particularly expanded polytetrafluoroethylene are used for
peripheral arterial revascularisation. Poor long term patency of prosthetic materials is due to distal anastomotic intimal
hyperplasia. Intimal hyperplasia is directly linked to shear stress abnormalities at the vessel wall. Compliance and calibre
mismatch between native vessel and graft, as well as anastomotic line stress concentration contribute towards unnatural
wall shear stress. High porosity reduces graft compliance by causing fibrovascular infiltration, whereas low porosity
discourages the development of an endothelial lining and hence effective antithrombogenicity. Therefore, consideration of
mechanical properties is necessary in graft development. Current research into synthetic vascular grafts concentrates on
simulating the mechanical properties of native arteries and tissue engineering aims to construct a new biological arterial
conduit.Keywords: Intimal hyperplasia; Vessel wall mechanics; Compliance; Porosity; Compliance mismatch; Polytetrafluor-
oethylene; Polyurethane; Vascular graft; Infrainguinal bypass; Graft caliber; Anastomosis.Introduction
Infrainguinal arterial bypass is one of the key vascular
procedures, with 12,810 revascularisation procedures
carried out in 1993 in the United Kingdom and a lower
limb critical ischaemia prevalence of 1 in 2500.1
Success is limited if a prosthetic graft is used or the
distal anastomosis crosses the knee joint (Fig. 1).
Where possible, autologous long saphenous vein is
used;2 however, this is not available or suitable in a
significant proportion of cases. Arm veins may be used
with primary patency of 60–85% at 3–5 years,3 the
difference with saphenous vein being attributable to
previous venepuncture, phlebitis, oversized diameter,
a propensity towards phlebitis and aneurysmal
dilatation. Human umbilical vein grafts have a highering author. Alexander M. Seifalian, PhD, Professor of
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0627+ 10 $35.00/0 q 2006 Elsevier Ltd. All rights reserpatency rate than prosthetic alternatives, but are prone
to aneurysm formation in the long term and their use
has not been widespread.4 Cryopreserved allografts
have 1-year patency rates of only 52%5 with the
additional complications of immunoreaction and
proximal post-anastomotic stenosis. Good patency
rates using deep vein segments are possible6 with
89% secondary patency at 3 years in selected patients,7
but the surgery is difficult and prolonged due to the
need for extensive dissection at proximal and distal
anastomotic sites; also the risk of severe venous
oedema as a result of venous outflow obstruction8
has meant that this approach has never been in favour.
The main prosthetic materials developed for bypass
grafting are polyethylene terephthalate (Dacron) and
polytetrafluoroethylene (PTFE). Dacron is manufac-
tured into a woven corrugated graft that is suitable for
high flow large vessel segment replacement, such as
diseased aorta replacement. However, recent random-
ized controlled trials9 have shown Dacron to be as
good as PTFE for infrainguinal bypass. PTFE has
achieved widespread use as a smaller diameterEur J Vasc Endovasc Surg 31, 627–636 (2006)
doi:10.1016/j.ejvs.2006.01.006, available online at http://www.sciencedirect.com onved.
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Fig. 1. Cumulative patency of vascular bypass grafts. Distal
bypass using PTFE has considerably worse patency than
proximal bypass or autologous vein grafting.10,65,66
S. Sarkar et al.628tubular graft. In above knee femoropopliteal revascu-
larisation, individual groups have published data to
suggest that the patency rates when using PTFE are
not significantly different to that for saphenous
vein.10,11 However, these studies lack power and a
meta-analysis showed that at every point in time, the
patency was greater when autologous saphenous vein
was used.2
Small diameter grafts (!6 mm) are especially liable
to blockage and research into the causes of this failure
and possible alternative materials with properties
more akin to the original artery has been undertaken
in recent times.
Between 2 and 24 months after bypass grafting,
intimal hyperplasia (IH) is responsible for poor
patency.12 Vascular endothelial cell damage triggers
IH formation. The postulated reasons for IH are
mechanical; the difference in compliance between
native vessel and graft; change in direction of flow at
the anastomosis; luminal diameter difference at the
anastomosis; vessel wall damage and suture tech-
nique. Interposing an autologous vein cuff making the
compliance mismatch more gradual, redistributes IH
away from the most critical areas of the anastomosis,
principally the heel, the toe and recipient artery floor,13
leading to some improvement in patency but keeping
the overall extent of IH unchanged.
Fluid dynamic studies reveal how endothelial
damage may result from compliance mismatch. The
cells are directly affected by altered stresses of blood
flow through the anastomosis, known as wall shear
stress (WSS). Even within the human arterial system,
the shear stress varies between different vessels14 withEur J Vasc Endovasc Surg Vol 31, June 2006superficial femoral artery mean wall shear rates of
130 sK1 comparedwith a carotid value of 333 sK1. WSS
also varies depending on physiological conditions
such as exercise. Experimental evidence suggests both
high and low15 shear stress cause IH. One explanation
for this is that it is the resultant flow pattern changes
rather than the shear stress itself that causes IH. Such
changes in shear stress include divergent flow
associated with low shear stress resulting in flow
separation, rarefaction and increased oscillatory shear.
On the other hand, there is convergent flow associated
with high shear stress, which is responsible for
endothelial cell injury.
The research into alternatives to ePTFE and Dacron
has concentrated on new materials with viscoelastic
properties similar to native artery, principally poly-
urethane due to its compliance and favourable
biocompatibility. This review aims to discuss the
critically important roles mechanical properties such
as viscoelasticity and haemodynamics play in main-
taining patency of infrainguinal bypass grafts.Basic Mechanical Theoretical Considerations
Poiseuille’s law states that the pressure drop in a tube
(P) is directly proportional to the tube length (L), the
rate of flow (Q) and the viscosity (h), and inversely
proportional to the fourth power of the internal radius
(ri) of that tube.
PZ
KLQh
r4i
(1)
Substituting the Ohms law analogy which states that
PZRQ (RZimpedance) and the value of K, calculated
experimentally:
RZ
8hL
pr4i
(2)
Therefore, when considering bypass conduits, the
impedance to flow is drastically increased by reducing
graft calibre, thereby reducing flow rate and increasing
the risk of stasis and so promoting thrombogenicity.
However, these equations relate only to pure
laminar flow in a rigid pipe—every particle is moving
parallel to the axis of the tube with a constant velocity.
Within one lamina, all particles will have the same
velocity and moreover, laminae near the centre of the
tube have greater velocity than more peripheral ones,
giving a parabolic flow profile (Fig. 2).
These theoretical considerations do not hold true
completely in the arterial system for numerous
reasons. First, the artery is not a rigid pipe. It is a
Fig. 3. The hysteresis cycle of viscoelasticity of an artery. See
text for detailed explanation.
Fig. 2. Laminar flow through a blood vessel.
Mechanical Properties of Vascular Bypass Grafts 629complexly compliant structure with intrinsic and
extrinsic mechanisms to vary compliance and shape,
and in so doing, contributing to the pressure for flow
itself. Next, blood flow only approaches laminar flow
in the largest arteries. Even in these vessels, the rate of
flow is not steady and it is only in diastole and early
systole that laminar flow is observed. Turbulent flow
due to branching vessels is also widespread. Blood is a
non-Newtonian fluid, being a suspension of particles
of various sizes. This makes its behaviour unpredict-
able, especially in small diameter vessels.
Nevertheless the laminar model can be used to
describe useful concepts in the investigation and
description of the mechanical properties of blood
vessels and flow. One such model is WSS.
The resistance R in Poiseuille’s formula relates to
the impedance to flow of a particle in one lamina
caused by the friction of the adjacent lamina. In the
same way, at the most peripheral lamina there is a
force exerted by the particles flowing here on the wall
of the vessel itself. This action against the wall is
termed WSS. Therefore, when considering the vessel
wall;
WSSZRZ
8hL
pr4i
(3)
The tendency for deformation of the vessel wall due
to pulsatile flow of blood through it is, within
physiological limits, elastic. This is to say that if the
blood force is removed, the vessel will return to its
previous shape. However, the force does not cause an
instantaneous deformation, like when a weight is
placed on a spring. The shape change, in the presence
of a constant force is a gradual one and the same is true
when the force is removed. This property of delay is
termed viscosity. The blood vessel demonstrates a
combined viscoelastic tendency.
Overall the mechanical behaviour of an artery is
complex. The ideal graft for anastomosis would
replicate this behaviour. In order to simplify the
investigation and description of this behaviour in
arteries and graft materials, the term ‘compliance’ is
used, encompassing the changing mechanicalproperties depending on the haemodynamic pressure
within the graft, unlike established physical concepts
such as Young’s modulus, E. At a given pressure P in a
vessel of diameter d and wall thickness t:
EZ
stress
strain
Z
Pd=2t
Dd=d
 
(4)
Rearranging this:
ComplianceZ
d
2Et
(5)
Therefore, compliance is inversely proportional to
vessel wall thickness. Manufacture of a synthetic graft
with a thinner wall results in greater distensibility.
Conversely, patients with peripheral vascular disease
already have increased intima-media thickness, con-
tributing to arterial rigidity.16
The overall result of the viscosity of the arterial wall
and its compliance (i.e. viscoelasticity) is to convert the
pulsatile ejection of the heart into a continuous flow,
storing a part of the energy of propulsion in systole
and restoring it to the circulation during diastole.
Therefore, viscoelasticity is important in energy
transfer and dissipation. All vascular tissues have
greater dimensions during unloading than during
loading, leading to a ‘hysteresis loop’ when the
pressure/diameter characteristics of the vessel are
plotted on a graph (Fig. 3). The area within the loop
represents the storage of energy in the vessel wall and
so viscosity, which is modulated by the vascular
endothelium. Investigations of the mechanical proper-
ties of arteries that have not specifically concentrated
on viscosity have measured the phase delay between
pulse pressure and distension. This method demon-
strates viscosity when considering a single pulse of
flow. However, in physiological pulsatile flow, the
alternating storage and discharge of energy by the
vessel wall leads to an intrinsic energy capacitance as
well as a continuous loss of energy, which is more
accurately measured from hysteresis loops.Eur J Vasc Endovasc Surg Vol 31, June 2006
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Fig. 4. Illustration of the para-anastomotic hypercompliance
zone. There is reduced compliance at the anastomotic line
with localized high compliance 2–3 mm either side of it.
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Non-mechanical causes for IH in vascular bypass
grafts include thrombogenicity; the absence of a
vascular endothelium to produce chemical signals
such as nitric oxide and non-biocompatibility.
There is widespread reporting that compliance
mismatch, rather than geometric factors, is primarily
responsible for IH17 and subsequent poor graft
patency as a result of turbulent flow (Table 1).18
Further flow disturbances are caused by injudicious
choice of anastomosis angle or bypass conduit calibre
at the time of surgery. Also, anastomotic stresses at the
suture line lead to IH independent of compliance
changes.12Pressure
Artery
AnastomosisPTFECompliance
It is the haemodynamic flow changes due to com-
pliance differences across an anastomosis, which both
cause increased shear stress to damage endothelial
cells and also reduced shear stress19 leading to areas of
relative stasis and increasing interaction between
platelets and vessel wall; pooling of chemokine
factors20 as well as increasing oscillatory forces. The
aim of matching compliance is to minimise these
disruptive flow characteristics.
The vortices created by compliance mismatch are
further complicated by localised high compliance, 2–
3 mm proximal and distal to the anastomotic line,
termed the ‘perianastomotic hypercompliance zone’
(PHZ)21,22 (Fig. 4). This contributes to giving the
overall perianastomotic region compliance properties
somewhere in between those of artery and graft
(Fig. 5). The artery’s J-shaped curve of compliance
shown in Fig. 5 demonstrates how it does not obey
Hooke’s law when subjected to pulsatile flow. This is
due to highly elastic elastin fibres controlling its
distension at low pressure flow and relatively inelastic
collagen fibres taking over at higher pressures.23 At
100 mmHg only 5–6% of collagen fibres are recruited
with progressive recruitment with rising pressure.Table 1. The positive correlation between graft compliance and
patency when used in infrainguinal bypass
Compliance* 1-year %
patency
2-year %
patency
Host artery 5.9 – –
Saphenous vein 4.4 88 84
Umbilical vein 3.7 83 80
Bovine heterograft 2.6 65 59
Dacron 1.9 65 42
EPTFE 1.6 60 42
* %radial change per mmHg!10K2. Adapted from Walden et al.18
Eur J Vasc Endovasc Surg Vol 31, June 2006Physiological influence causes recruitment of vascular
smooth muscle cells in conjunction with some collagen
fibres with elastin fibres bearing the remaining share
of the stress.24
Design of alternatives to PTFE has concentrated on
achieving a compliant structure. This has been
approached in several ways including porous
‘spongy’ materials25 and double tubular grafts with a
more compliant inner lining and a less compliant outer
layer.26 As these latter grafts are distended, they
become progressively less compliant as the outer
sleeve properties become more prominent. Our unit
has produced and characterized porous compliant
poly(carbonate)polyurethane (CPU) grafts (Myo-
linke)27–29 (Fig. 6).
Another aspect of interest to graft designers is the
long term change in compliance after implantation.
The artery has an astonishing capacity to maintain its
intrinsic compliance despite abnormal chronic phys-
iological changes such as hypertension.30 This is
observed to cause wall thickening but compliance is
largely unaffected due to intrinsic changes in the
vessel wall properties.31 Interestingly, when a vein
graft is used, it undergoes wall thickening and does
not lose its compliance properties.18 However,Diameter
Fig. 5. For an anastomosis between ePTFE and native artery,
the per-anastomotic compliance is intermediate between that
of its constituent vessels.67
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Fig. 6.Variation of compliance vs.mean pressure for different
conduits. The pulse pressure was 60 mmHg. CPU is a
compliant prosthesis unlike ePTFE and Dacron.23
Mechanical Properties of Vascular Bypass Grafts 631the effect of the surrounding tissues on an implanted
prosthetic graft is to reduce compliance with time. This
is especially the case in porous structures with a pore
size greater than 45 mm when considerable fibrous
tissue ingrowth takes place.
Compliance measurement is achieved by the
investigation of distension due to pressure changes
within a conduit and a range of methods have been
used as described in Salacinski et al’s recent review.320 2 4 6 8 10
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Fig. 7. Proportional cross-section area as a result of 1 mm
graft stenosis. The consequence of a 1 mm graft stenosis is
much greater in a small caliber vessel than in a large
diameter conduit.Conduit Calibre
Poiseuille’s law shows that the pressure of flow for
blood through a conduit is inversely proportional to
the fourth power of its radius. When considering an
implanted bypass graft with no side branches, a
purposeful tapering of the graft would lead to a
massive concentration of pressure across it.33 The
natural tapering of the vasculature distally is workable
without pressure increases due to extensive branching
of the native vessels.
Treiman et al.s’34 duplex studies show that a larger
diameter venous graft is associated with lower distal
graft velocity. For above knee femoropopliteal35 and
for coronary artery bypass36 it has been confirmed
clinically that larger diameter grafts confer better
patency rates than smaller conduits. This explains
how reduced flow velocity at the anastomotic floor of
the Venafloe cuffed PTFE anastomosis prevents
excessive shear stress, translating to reduced IH.37
High flow at the larger proximal anastomosis is
partially protective as it allows for the rapid dispersal
of chemotactic factors released due to endothelial
injury. It is the smaller distal anastomosis where the
majority of IH is seen. Here, particularly in an
infragenicular bypass even a slight thickening of theintima will cause a considerable stenosis, compared
with a large calibre vessel (Fig. 7). Stenosis promotes
platelet adherence and thrombosis. A vein cuff or the
Distafloe PTFE graft widens the distal anastomosis
and both are used clinically with better patency than
PTFE alone.38
Conversely, a grossly oversized distal conduit will
result in a sudden decrease in flow rate with relative
stasis and flow separation. The resultant low shear rate
is associated with IH as discussed earlier. Hence, the
ideal diameter difference between graft and artery at
the distal anastomosis is a balance to maintain the
ideal flow velocity and resist turbulent flow.Anastomotic Line Stresses
The creation of an end-to-end (ETE) anastomosis itself
reduces compliance at the suture line.39 A continuous
suture technique causes a greater loss of compliance
than interrupted sutures with greater concentration of
stresses at the suture line tethering it against
distension. Clips that do not penetrate the intima
also results in an anastomosis with less compliance
mismatch (CM).21How Porosity Affects Mechanical Properties
The artery is a selectively permeable structure and a
microporous architecture in a prosthesis has been
shown to mimic arterial function.
Endothelialisation of the luminal aspect of a graft
comes about directly from the artery edge at the
anastomotic site as well as via fibrovascular infiltration
from the surrounding tissues. It is this fibrovascular
infiltration that allows speedy uniform lining of a longEur J Vasc Endovasc Surg Vol 31, June 2006
S. Sarkar et al.632graft. Zhang et al.40 showed that with physiological
pulsatile flow in an animal model, full ordered
endothelialisation of a small diameter prosthesis is
possible within 8 weeks, providing a pore size of
30 mm diameter. They also demonstrated that the
external aspect pore size correlated with the rate of
endothelialisation. White et al.’s41 review of pore size
shows that the ideal pore size for fibrovascular
infiltration is between 10 and 45 mm. However, larger
pores allow too much surrounding fibrous tissue
invasion risking a dramatic loss of compliance.42
It has been showed that porous CPU promoted
successful seeding of endothelial cells onto its sur-
face.43 By isolating the effects of surrounding tissues
and fibrovascular infiltration in a laboratory model, it
has been showed that after initial seeding, a porous
graft allows stronger endothelial cell adherence when
exposed to pulsatile flow than smooth ePTFE.44
PTFE grafts with low porosity were explanted after
a mean implantation time of 523 days, from human
subjects and examined.45 It was found that cellular
infiltration into the grafts was poor, with mostly thin
patchy fibrin cover to the lumen.
Therefore, in the development of a new graft, the
precise measurement of its porosity is critical. This has
been addressed since 1961 when Wesolowski et al.46
used a machine to compress the graft wall and
measure the rate of flow of water through the wall at
a water pressure of 120 mmHg. They found this
measure to be highly reproducible.The Importance of Burst Pressure
This relates to the pressure that the vascular conduit
can be subjected to before an acute leak develops and
the conduit fails. The maximum force, f, applicable to
any material is represented by:
f Z
Pd
2t
(6)
where P, d and t are (burst) pressure, diameter and
wall thickness, respectively.
Therefore, it can be seen that the burst pressure
decreases with increasing diameter and with decreas-
ing wall thickness, since f is a finite entity. It is,
therefore, very likely that the burst pressure for a
small diameter graft will far exceed the physiological
range of blood pressures possible in man. For
example, the burst pressure of a typical carotid artery
is in the region of 5000 mmHg and for a saphenous
vein is around 2250 mmHg. Burst pressure of
porous polyurethane grafts have been found to beEur J Vasc Endovasc Surg Vol 31, June 20061850–2050 mmHg,47 again much greater than any
possible physiological blood pressure.Aneurysmal Change
Elastin degradation, notably by matrix metalloprotei-
nases (MMP) 2 and 9, initiates aneurysmal change in
an artery. This serves to remove elastin’s stress
buffering properties, transferring more force straight
to collagen. The breakdown of type I collagen,
mediated byMMP 8,48 ensures expansion and possible
rupture of the aneurysm.
Aneurysmal change in PTFE is now a rare event,
since reinforcement of PTFE grafts was introduced in
1977. Similarly knitted Dacron peripheral bypass
prostheses have in the past occasionally become
aneurysmal, due to initial yarn slippage and stretch-
ing49 leading to material fatigue, fraying and breakage
in association with biodegradation of the frayed
fibres.50 This in turn has lead to excessive stress in
adjacent fibres, which are taking an increased strain.
However, modern manufacturing techniques have
eliminated aneurysmal dilatation of Dacron.
The failure of a polyurethane graft to cope with
cyclical circumferential stretching can be predicted
from the order of magnitude of its experimentally
derived burst pressure. However, the pressure at
which aneurysmal dilatation occurs in vivo is lower
than the absolute burst pressure, with other contribut-
ing factors being the level of autologous tissue
ingrowth to aid structural integrity externally; as
well as biodegradation.Properties of Bypass Conduits in Clinical UseMechanical properties of autologous vein
Unlike the arterial system, veins do not have to deal
with pressures greater than 75 mmHg and have a
lower compliance range than arteries due to a lower
collagen:elastin ratio and much less smooth muscle.
Their role is to maximize capacitance rather than to
contribute to pulsatile flow transmission. However, a
venous graft anastomosed to an artery will suddenly
overdistend to its limit. This will lead to immediate de-
endothelialisation.51 The sequence of events over the
next 30 days is often termed ‘arterialisation’. This
involves luminal wall platelet deposition; vascular
smooth muscle cell (SMC) apoptosis and necrosis;
monocytic infiltration; adventitial fibroblastic activity
and angiogenesis; myointimal thickening with media
Mechanical Properties of Vascular Bypass Grafts 633SMC proliferation and infiltration. Finally, there is re-
endothelialisation.
From 3 months onwards, considerable remodelling
of a venous graft in situ has been shown to occur.52
There is wall thickening with concomitant reduction in
wall tension; lumen size changes depending on the
initial lumen size with lumens larger than 3.75 mm in
diameter actually getting smaller; and a significant
increase in wall stiffness. These changes along with re-
endothelialisation equip the graft for use as an arterial
conduit. This is reflected in the sizeable failure rate for
venous grafts in the 1st year compared with sub-
sequent annual occlusion rates.53
Due to low elastin levels compared with an artery,
the overdistension caused by arterial blood pressure
gives the vein poor compliance properties, making it
in effect a rigid tube. Stooker et al.54 found lower leg
saphenous vein to be more distensible than its upper
leg equivalent in the venous pressure range. Davies et
al.55 found that compliance of a vein was inversely
proportional to both circular muscle hypertrophy and
focal hyperplasia, confirming that the thicker-walled
distal saphenous vein segments show less compliance.
However, this latter study was an in vivo investigation
with the confounding effect of surrounding tissues on
compliance.Mechanical properties of ePTFE
ePTFE is very stable in vivo with no reported failures
due to degradation of the graft.45 It is poorly
compliant, made up of fibrils extruded into a tubular
structure with moderate stiffness.32 Perivascular
reaction reduces its compliance further to only 14%
of its pre-implantation level. The gaps between the
fibrils form micropores which are so small (!0.05 mm)
that many studies consider it to be a non-porous
material.56 Because of this ePTFE grafts have very poor
lumenal endothelialisation in vivo.45 Higher porosity
can be conferred to PTFE by constructing a graft with a
larger fibril size (60 vs. 20 mm) leading to the
promotion of transmural tissue growth.57Mechanical properties of Dacron
Polyethylene terephthalate or Dacron is composed of
tightly woven or knitted fibres of very high tensile
strength (10-fold that of PTFE).32 Individually, the
microfibres are susceptible to slow hydrolytic degra-
dation, but their highly crystalline ordered structure
prevents this. The knitted graft is highly porous and
the need for preclotting may be avoided by presealing
with gelatin or albumen. Crimping of the conduit orexternal reinforcement is required to prevent kinking,
especially if the graft is to cross the knee joint. Initial
unfavourable comparison with saphenous vein in
peripheral bypass was in part due to the absence of
antiplatelet therapy but modern trials suggest they are
at least as good as PTFE for above-knee femoropopli-
teal bypass.9,58Prostheses of the future
Synthetic grafts
The search for new compliant prostheses to replace
ePTFE has concentrated on polyurethane materials25
due to their favourable biocompatibility. The funda-
mental building block for these polymers is a
repeating sequence of urethane:
–NHðCOÞO– (7)
They consist of a hard segment and a soft segment
to give strength and elasticity, respectively.
Polyurethane has yet to be used clinically as an
infrainguinal bypass graft. Before this can occur,
further research into compliant polyurethane develop-
ment with particular consideration of anti-thrombo-
genic properties and endothelialisation in vivo is
required. In addition, a host of different manufactur-
ing processes have been identified and the most
suitable one needs to be identified in terms of
reproducibility and quality control.
Tissue engineered grafts
A biological arterial substitute incorporating the
cellular layers of the native vessel can reflect the
adaptable mechanical properties of the artery as well
as providing its inherent antithrombogenicity.
A biodegradable scaffold can provide a template on
which the cellular components can align and the
overall structure can mature with collagen being laid
down potentially resulting in ideal mechanical proper-
ties in the long term.59 Such tubes achieve good burst
and suture retention strength.60 Burst strength
is increased by prolonging in vitro culture pre-
implantation with the downside of compliance loss
(Table 2).61
It is possible to create tissue engineered vessels
without a scaffold by forming tissue around mandrels
implanted subcutaneously62 or intraperitoneally.63 This
technique uses the body’s own foreign body reaction
to form a myofibroblast and collagen matrix which is
robust enough to be implanted as a vascular prosthesis
in that same body. Pulsatile flow causes matrix
thickening with further collagen deposition and elastic
lamellae formation; myofibroblast differentiation intoEur J Vasc Endovasc Surg Vol 31, June 2006
Table 2. Prolonged culture increases burst strength of seeded PGA
grafts.61
Culture time (weeks) Burst strength (mmHg)
3 Too fragile to manipulate
5 (nZ4) 570G100
8 (nZ3) 2150G700
S. Sarkar et al.634SMCs along with their circular alignment.63 However,
ultimately this technology requires an invasive pro-
cedure to implant a foreign body intraperitoneally in
the recipient human. The consequences of infection
would be very serious in patients with critical
ischaemia especially since they are usually already at
high medical risk.
Therefore, it would be desirable to construct a fully
tissue-engineered graft made up of autologous cells ex
vivo. L’Heureux’s group64 achieved burst pressures of
2594G501 mmHg with a tubular structure made from
coaxial sheets of cultured vascular SMCs and human
fibroblasts which was seeded with endothelial cells.
This was as a result of a well organized collagen matrix
with parallel fibres in perpendicular bundles. Elastin
fibres were also seen. The overall structure was
macroscopically and microscopically similar to an
artery.Conclusion
The ideal vascular bypass graft would replicate the
mechanical properties of native artery perfectly to
maximize patency. In particular, it would demonstrate
viscoelasticity for efficient pulsatile flow, matched
compliance to prevent IH and have a burst pressure
well above the physiological range of haemodynamic
pressures. It would be porous enough to encourage
transmural cell growth and endothelialisation but not
so porous as to cause fibrous infiltration with
subsequent loss of compliance. Approaches towards
this goal are the engineering of synthetic poly-
urethane-based grafts and the individualized tissue-
engineered graft. The latter could theoretically achieve
a true artificial artery, but will have the disadvantage
of requiring considerable time for its generation,
whereas a synthetic graft has ‘off the shelf’ appeal.References
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